Awarded Contractocds-h6vhtk-066916

Herpes zoster, inactivated vaccine (2027)

The provision of a vaccine to protect against herpes zoster, also known as shingles, to be used in the national immunisation programme. This notice provides an indication to the market of UKHSA’s intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the herpes zoster, inactivated (shingles) vaccine, in accordance with JCVI advice.

Buyer

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Value

£0

Published

13 Mar 2026

Closes

13 Mar 2026

Procurement details

Source

Find a Tender

Region

Tower Hamlets

Procurement method

Direct

Category

Goods

Contract starts

31 Mar 2027

Contract ends

31 Mar 2029

CPV classifications

33651600

Vaccines

Lots

Lot 1 Herpes zoster, inactivated vaccine (2027)

£0

Documents

Unlock document link

Transparency notice on Find a Tender

13 Mar 2026

Transparency notice on Find a Tender

Award notice · UK5 · Web page

Contains public sector information licensed under the Open Government Licence v3.0.